Literature DB >> 8240052

[Chagas disease and primary arterial hypertension].

M E Guariento1, M de C Ramos, J A Gontijo, S dos S Carvalhal.   

Abstract

PURPOSE: To evaluate the pressoric behaviour in chagasic patients in different stages of myocardial damage and to correlate Chagas' disease with arterial hypertension.
METHODS: The arterial blood pressure of 644 chagasic patients surveyed in the HC-UNICAMP, with arterial hypertension or not, associated with the stage of myocardial dysfunction was evaluated. This group was compared with 370 hypertensive patients without Chagas' disease. Both were divided by sex and age. The results were evaluated by covariance analysis and the significance was pointed at p < 0.05.
RESULTS: The chagasic group presented a high prevalence of arterial hypertension with 16.8% in the clinical phase I, 27.8% in the phase II and 34% in the III. Both hypertensive and nonhypertensive chagasic patients had a significant drop in clinical phase I after the age of 30 years. The chagasic patients classified in phase II presented a high prevalence between 30-50 years, not associated with the pressoric behaviour and/or sex. The symptomatic myocardial dysfunction (phase III) was uncommon below 40 years old in chagasic group with hypertension or not, but presented a highest prevalence in male hypertensive chagasic patients above 50 years old.
CONCLUSION: The study demonstrated a more usual association of Chagas' disease and hypertension in patients with symptomatic myocardial dysfunction, above 50 years old. This find evidenciates the somatory and progressive effect of both diseases. It is possible that the pathogenic mechanisms of Chagas' disease contributed to the increment of the arterial blood pressure.

Entities:  

Mesh:

Year:  1993        PMID: 8240052

Source DB:  PubMed          Journal:  Arq Bras Cardiol        ISSN: 0066-782X            Impact factor:   2.000


  4 in total

1.  New Scheme of Intermittent Benznidazole Administration in Patients Chronically Infected with Trypanosoma cruzi: Clinical, Parasitological, and Serological Assessment after Three Years of Follow-Up.

Authors:  María Gabriela Álvarez; Juan Carlos Ramírez; Graciela Bertocchi; Marisa Fernández; Yolanda Hernández; Bruno Lococo; Constanza Lopez-Albizu; Alejandro Schijman; Carolina Cura; Marcelo Abril; Susana Laucella; Rick L Tarleton; María Ailen Natale; Melisa Castro Eiro; Sergio Sosa-Estani; Rodolfo Viotti
Journal:  Antimicrob Agents Chemother       Date:  2020-08-20       Impact factor: 5.191

2.  Biomarkers assessment in patients with Chagas disease and systemic arterial hypertension.

Authors:  Anderson de Oliveira Vieira; Gabriel Antônio Nogueira Nascentes; Ana Carolina de Morais Oliveira; Dalmo Correia; Marlene Cabrine-Santos
Journal:  Parasitol Res       Date:  2020-11-11       Impact factor: 2.289

3.  Clinical and epidemiological profile of elderly patients with Chagas disease followed between 2005-2013 by pharmaceutical care service in Ceará State, Northeastern Brazil.

Authors:  Laíse dos Santos Pereira; Erlane Chaves Freitas; Arduína Sofia Ortet de Barros Vasconcelos Fidalgo; Mônica Coelho Andrade; Darlan da Silva Cândido; José Damião da Silva Filho; Vladimir Michailowsky; Maria de Fátima Oliveira; José Ajax Nogueira Queiroz
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2015 Mar-Apr       Impact factor: 1.846

4.  Progression Rate from the Indeterminate Form to the Cardiac Form in Patients with Chronic Chagas Disease: Twenty-Two-Year Follow-Up in a Brazilian Urban Cohort.

Authors:  Alejandro Marcel Hasslocher-Moreno; Sergio Salles Xavier; Roberto Magalhães Saraiva; Luiz Henrique Conde Sangenis; Marcelo Teixeira de Holanda; Henrique Horta Veloso; Andrea Rodrigues da Costa; Fernanda de Souza Nogueira Sardinha Mendes; Pedro Emmanuel Alvarenga Americano do Brasil; Gilberto Marcelo Sperandio da Silva; Mauro Felippe Felix Mediano; Andrea Silvestre de Sousa
Journal:  Trop Med Infect Dis       Date:  2020-05-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.